Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer
Other
OA: closed
AI-generated summary
The automated tube leucocyte-adherence inhibition assay detected tumour-specific immunity to pancreatic antigens in patients with localised and extensive pancreatic cancer, while showing no reactivity to antigens from other gastrointestinal or lung malignancies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Tumour-specific immunity to pancreatic tumour antigens, assayed by an automated tube leucocyte-adherence inhibition assay (L.A.I.), was detected in 3 of 3 patients with localised pancreatic cancer and 3 of 8 patients with more extensive pancreatic cancer. Leucocytes from pancreatic cancer patients with L.A.I. reactivity did not react to antigens of stomach, colon, or lung tumours; leucocytes from patients with stomach, colon, or lung cancer of inflammatory disease of the pancreas and bowel did not show L.A.I. reactivity to pancreatic tumour antigens.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- pubmed
- last seen: 2026-10-08T21:59:01.426159+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00